ETF Holdings Breakdown of RLAY

Stock NameRelay Therapeutics Inc
TickerRLAY(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS75943R1023

News associated with RLAY

MetLife Investment Management LLC Acquires 16,477 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY)
MetLife Investment Management LLC increased its holdings in shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 28.6% in the fourth quarter, Holdings Channel.com reports. The fund owned 74,166 shares of the company’s stock after buying an additional 16,477 shares during the quarter. MetLife Investment Management LLC’s holdings in Relay Therapeutics were worth $306,000 […] - 2025-05-08 07:56:55
189,046 Shares in Relay Therapeutics, Inc. (NASDAQ:RLAY) Purchased by Raymond James Financial Inc.
Raymond James Financial Inc. acquired a new stake in shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) during the 4th quarter, HoldingsChannel.com reports. The fund acquired 189,046 shares of the company’s stock, valued at approximately $779,000. Other institutional investors also recently modified their holdings of the company. Barclays PLC lifted its position in shares […] - 2025-05-07 08:46:50
Relay Therapeutics, Inc. (NASDAQ:RLAY) Stock Position Reduced by Wells Fargo & Company MN
Wells Fargo & Company MN trimmed its position in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 45.3% in the fourth quarter, Holdings Channel.com reports. The fund owned 71,425 shares of the company’s stock after selling 59,042 shares during the period. Wells Fargo & Company MN’s holdings in Relay Therapeutics were worth $294,000 as of […] - 2025-05-07 07:52:58
Renaissance Technologies LLC Grows Position in Relay Therapeutics, Inc. (NASDAQ:RLAY)
Renaissance Technologies LLC grew its stake in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 130.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,549,190 shares of the company’s stock after buying an additional 878,095 shares during the […] - 2025-04-20 08:00:52
JPMorgan Chase & Co. Reduces Position in Relay Therapeutics, Inc. (NASDAQ:RLAY)
JPMorgan Chase & Co. decreased its holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 9.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,978,443 shares of the company’s stock after selling 539,073 shares during the period. JPMorgan Chase & […] - 2025-04-11 09:20:51
American Century Companies Inc. Purchases 51,499 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY)
American Century Companies Inc. increased its position in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 23.3% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 272,166 shares of the company’s stock after buying an additional 51,499 shares during the quarter. American Century Companies Inc.’s holdings in Relay Therapeutics were worth $1,121,000 at the […] - 2025-04-11 07:34:48
Prudential Financial Inc. Buys 173,000 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY)
Prudential Financial Inc. grew its position in shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 45.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 549,645 shares of the company’s stock after acquiring an additional 173,000 shares during the quarter. Prudential Financial […] - 2025-04-04 07:37:00
Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Bought by Teacher Retirement System of Texas
Teacher Retirement System of Texas grew its stake in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 19.5% in the fourth quarter, Holdings Channel reports. The fund owned 33,720 shares of the company’s stock after purchasing an additional 5,492 shares during the period. Teacher Retirement System of Texas’ holdings in Relay Therapeutics were worth $139,000 […] - 2025-04-03 07:54:50
Cibc World Markets Corp Buys New Position in Relay Therapeutics, Inc. (NASDAQ:RLAY)
Cibc World Markets Corp purchased a new position in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 11,388 shares of the company’s stock, valued at approximately $47,000. Several other large investors also recently bought and […] - 2025-03-28 08:18:47
Bank of New York Mellon Corp Purchases 50,190 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY)
Bank of New York Mellon Corp raised its position in shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 18.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 328,897 shares of the company’s stock after acquiring an additional 50,190 shares […] - 2025-03-24 07:10:52
Relay Therapeutics (NASDAQ:RLAY) vs. Kyverna Therapeutics (NASDAQ:KYTX) Financial Survey
Kyverna Therapeutics (NASDAQ:KYTX – Get Free Report) and Relay Therapeutics (NASDAQ:RLAY – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, risk, profitability, analyst recommendations and dividends. Insider & Institutional Ownership 18.1% of Kyverna […] - 2025-03-21 05:51:04
Los Angeles Capital Management LLC Acquires 20,880 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY)
Los Angeles Capital Management LLC increased its holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 65.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 52,770 shares of the company’s stock after purchasing an additional 20,880 shares during the period. […] - 2025-03-05 10:41:42
Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Bought by China Universal Asset Management Co. Ltd.
China Universal Asset Management Co. Ltd. raised its position in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 37.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 35,491 shares of the company’s stock after purchasing an additional 9,740 shares […] - 2025-02-04 08:53:08

RLAY institutional holdings

The following institutional investment holdings of RLAY have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-09 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 102,948USD 308,844
2025-05-09 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 63,613USD 190,839
2025-05-09 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 183,744USD 551,232
2025-05-09 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 81,044USD 243,132
2025-05-09 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 81,044USD 243,132
2025-05-09 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 2,310USD 6,930
Total =514,703 USD 1,544,109
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.